| Title |
Author |
Type |
Date |
Words |
| Efficacy of sacubitril/valsartan combined with dapagliflozin in treating patients with heart failure and diabetes after an acute myocardial infarction. |
Lifang Zhang, Xiuying Tang, Runjun Li, Jinxia Niu and Jie Gong |
|
Dec 4, 2024 |
2608 |
| Dysregulated renal tubular handling of filtered glucose in patients with type 2 diabetes mellitus: A descriptive study. |
Zulfiqar, Asim; Jahan, Saira; Khan, Muhammad Nadim Akbar; Burney, Shamaila; Farooq, Muhammad; Fatima |
Report |
Nov 12, 2024 |
2472 |
| Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection? |
Castillo, Rodrigo L.; Farías, Jorge; Sandoval, Cristian; González-Candia, Alejandro; Figueroa, Esteb |
Report |
Nov 1, 2024 |
15551 |
| Coronary Plaque Regression and Fractional Flow Reserve Improvement in a Chronic Coronary Syndrome Case: Early Optimal Medical Therapy and Fractional Flow Reserve-Computed Tomography Follow-Up Strategy. |
Yoshimitsu, Yuki; Awaya, Toru; Kawagoe, Naoyuki; Kunimasa, Taeko; Iijima, Raisuke; Hara, Hidehiko |
Clinical report |
Nov 1, 2024 |
4566 |
| Effects of Sodium–Glucose Co-Transporter 2 Inhibitors on Serum Chloride Concentrations in Patients with Heart Failure. |
Jurin, Ivana; Ivanovic Mihajlovic, Vanja; Šakic, Zrinka; Pavlov, Marin; Šipic, Tomislav; Vitlov, Pet |
Clinical report |
Nov 1, 2024 |
8877 |
| The Potential Impact of SGLT2-I in Diabetic Foot Prevention: Promising Pathophysiologic Implications, State of the Art, and Future Perspectives—A Narrative Review. |
Miceli, Giuseppe; Basso, Maria Grazia; Pennacchio, Andrea Roberta; Cocciola, Elena; Pintus, Chiara; |
|
Nov 1, 2024 |
19104 |
| Heart Failure Associated with Giant Uterine Leiomyoma: A Case Report. |
Hsu, Hai-Ning; Hsu, Fang-Chin; Hung, Yuan; Hsu, Po-Chao; Su, Kuo-Min |
|
Nov 1, 2024 |
2983 |
| The Five Pillars of Acute Right Ventricular Heart Failure Therapy: Can We Keep the Pediment in Balance? |
Petris, Antoniu Octavian; Pop, Calin; Cimpoesu, Diana Carmen |
Report |
Nov 1, 2024 |
4814 |
| Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current Literature. |
Prosperi, Silvia; D’Amato, Andrea; Labbro Francia, Aurora; Monosilio, Sara; Cestiè, Claudia; Marek I |
Report |
Nov 1, 2024 |
7901 |
| Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study. |
Volpe, Sara; Vozza, Alfredo; Lisco, Giuseppe; Fanelli, Margherita; Racaniello, Davide; Bergamasco, A |
Clinical report |
Nov 1, 2024 |
8866 |
| Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update. |
Profili, Nicia I.; Castelli, Roberto; Gidaro, Antonio; Manetti, Roberto; Maioli, Margherita; Delital |
|
Nov 1, 2024 |
7371 |
| Advice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and Disallowing Studies Where Bioavailability Is Not Proven. |
Niazi, Sarfaraz K. |
|
Nov 1, 2024 |
8130 |
| Extended duration linagliptin nanoparticles: a novel, safe and effective future of diabetes treatment? |
Muhammad Hamayal, Saira Mahmud and Warda Shahid |
|
Oct 9, 2024 |
647 |
| SGLT2 Inhibitors and the Risk of Contrast-Associated Nephropathy Following Angiographic Intervention: Contradictory Concepts and Clinical Outcomes. |
Heyman, Samuel N.; Aronson, Doron; Abassi, Zaid |
Report |
Oct 1, 2024 |
8659 |
| Prognostic Impact of Statins in Heart Failure with Preserved Ejection Fraction. |
Ortega-Hernández, Samanta; González-Sosa, Sonia; Conde-Martel, Alicia; Trullàs, Joan Carles; Llàcer, |
Report |
Oct 1, 2024 |
8141 |
| Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease. |
Braha, Adina; Timar, Bogdan; Ivan, Viviana; Balica, Monica Miclo?; Daniluc, Larisa; Timar, Romulus |
Report |
Oct 1, 2024 |
9235 |
| Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study. |
Schwegel, Nora; Toferer, Christina; Zach, David K.; Santner, Viktoria; Höller, Viktoria; Lugitsch, J |
Report |
Oct 1, 2024 |
4626 |
| Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action. |
Piperis, Christos; Marathonitis, Anastasios; Anastasiou, Artemis; Theofilis, Panagiotis; Mourouzis, |
Report |
Oct 1, 2024 |
10058 |
| Correction: Balleza Alejandri et al. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. J. Cardiovasc. Dev. Dis. 2024, 11, 182. |
Balleza Alejandri, Luis Ricardo; Grover Páez, Fernando; González Campos, Erick; Ramos Becerra, Carlo |
|
Oct 1, 2024 |
554 |
| The Extracellular Matrix and Cardiac Pressure Overload: Focus on Novel Treatment Targets. |
Snelders, Matthijs; Yildirim, Meltem; Danser, A. H. Jan; van der Pluijm, Ingrid; Essers, Jeroen |
|
Oct 1, 2024 |
8520 |
| Endothelin Inhibitors in Chronic Kidney Disease: New Treatment Prospects. |
Rakotoarison, Agata; Kepinska, Marta; Konieczny, Andrzej; Wladyczak, Karolina; Janczak, Dariusz; Hal |
Report |
Oct 1, 2024 |
7102 |
| Amiodarone Therapy: Updated Practical Insights. |
Sorodoc, Victorita; Indrei, Lucia; Dobroghii, Catinca; Asaftei, Andreea; Ceasovschih, Alexandr; Cons |
Disease/Disorder overview |
Oct 1, 2024 |
15667 |
| The Potential Use of Targeted Proteomics and Metabolomics for the Identification and Monitoring of Diabetic Kidney Disease. |
Van Roy, Nele; Speeckaert, Marijn M. |
|
Oct 1, 2024 |
9835 |
| The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes. |
Vergani, Michela; Cannistraci, Rosa; Perseghin, Gianluca; Ciardullo, Stefano |
Report |
Oct 1, 2024 |
9228 |
| Correction: Ng et al. Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome. Nutrients 2021, 13, 4088. |
Ng, Hwee-Yeong; Kuo, Wei-Hung; Tain, You-Lin; Leung, Foong-Fah; Lee, Wen-Chin; Lee, Chien-Te |
|
Oct 1, 2024 |
235 |
| Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1a/PPARa and KEAP1/NRF2 Pathways. |
Zhang, Mengqing; Guo, Chengcheng; Li, Zonglin; Cai, Xiaoling; Wen, Xin; Lv, Fang; Lin, Chu; Ji, Lino |
Report |
Oct 1, 2024 |
7446 |
| Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study. |
Rodríguez-Miguel, Antonio; Fernández-Fernández, Beatriz; Ortiz, Alberto; Gil, Miguel; Rodríguez-Mart |
Clinical report |
Oct 1, 2024 |
7804 |
| MYOCARDIAL BRIDGING-A CONUNDRUM? |
dos Santos, Vitorino Modesto; Tedeschi, Andressa Placa; Modesto, Laura Campos; Modesto, Julia Campos |
Letter to the editor |
Oct 1, 2024 |
931 |
| Novel Analytical Method for Combined Dapagliflozin and Vildagliptin in Bulk and Pharmaceutical Dosage Form Using HPLC. |
Khagga, Bhavyasri; Nandini, Musquri; Sowjanya, Danda; Rambabu, Dammu; Mogili, Sumakanth |
Report |
Oct 1, 2024 |
2464 |
| The Impact of Interdisciplinary Care Teams in Value-Based Kidney Care: Insights from Case Study Reports. |
Cahill, Molly L.; Paulus, Amber B. |
Clinical report |
Sep 1, 2024 |
3779 |
| Cancer and Heart Failure: Dangerous Liaisons. |
Bertolini, Davide; Pizzi, Carmine; Donal, Erwan; Galli, Elena |
|
Sep 1, 2024 |
13642 |
| Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines. |
Cristovão, André; Andrade, Nelson; Martel, Fátima; Silva, Cláudia |
Report |
Sep 1, 2024 |
9427 |
| Recent Advances in Understanding the Molecular Mechanisms of SGLT2 Inhibitors in Atrial Remodeling. |
Minciuna, Ioan-Alexandru; Tomoaia, Raluca; Mihaila, Dragos; Cismaru, Gabriel; Puiu, Mihai; Ro?u, Rad |
|
Sep 1, 2024 |
9152 |
| The Influence of Non-Pharmacological and Pharmacological Interventions on the Course of Autosomal Dominant Polycystic Kidney Disease. |
Kedzierska-Kapuza, Karolina; Lopuszynska, Inga; Niewinski, Grzegorz; Franek, Edward; Szczuko, Malgor |
|
Sep 1, 2024 |
10652 |
| The Influence of Dapagliflozin on Foot Microcirculation in Patients with Type 2 Diabetes with and without Peripheral Arterial Disease—A Pilot Study. |
Bradaric, Božena; Bulum, Tomislav; Brkljacic, Neva; Mihaljevic, Željko; Benic, Miroslav; Bradaric Li |
Report |
Sep 1, 2024 |
9220 |
| Is Arterial Stiffness Interconnected with Cardiovascular Drug Prescription Patterns, Body Composition Parameters, and the Quality of Blood Pressure Regulation in Hypertensive Patients? |
Radic, Josipa; Vuckovic, Marijana; Ðogaš, Hana; Gelemanovic, Andrea; Belancic, Andrej; Radic, Mislav |
Clinical report |
Sep 1, 2024 |
6216 |
| Dapagliflozin: A Promising Strategy to Combat Cisplatin-Induced Hepatotoxicity in Wistar Rats. |
Satyam, Shakta Mani; Bairy, Laxminarayana Kurady; Rehman, Abdul; Farook, Mohamed; Khan, Sofiya; Nair |
|
Sep 1, 2024 |
7556 |
| The Interplay between Severe Cirrhosis and Heart: A Focus on Diastolic Dysfunction. |
Lupu, Drago?; Nedelcu, Lauren?iu; ?în?, Diana |
Report |
Sep 1, 2024 |
6314 |
| Epicardial Fat in Heart Failure with Preserved Ejection Fraction Compared with Reduced Ejection Fraction. |
Sidhu, Gurwinder S.; Rabkin, Simon W. |
Report |
Sep 1, 2024 |
7648 |
| Concomitance of Pericardial Tamponade and Pulmonary Embolism in an Invasive Mucinous Lung Adenocarcinoma with Atypical Presentation: Diagnostic and Therapeutic Pitfalls—Case Report and Literature Review. |
Bertici, Nicoleta Sorina; Tudoran, Cristina; Bertici, Razvan Adrian; Fira-Mladinescu, Ovidiu; Jianu, |
|
Aug 1, 2024 |
6673 |
| Acute Hyperglycemia-Induced Injury in Myocardial Infarction. |
Pepe, Martino; Addabbo, Francesco; Cecere, Annagrazia; Tritto, Rocco; Napoli, Gianluigi; Nestola, Pa |
|
Aug 1, 2024 |
8378 |
| The Beneficial Effect of the SGLT2 Inhibitor Dapagliflozin in Alleviating Acute Myocardial Infarction-Induced Cardiomyocyte Injury by Increasing the Sirtuin Family SIRT1/SIRT3 and Cascade Signaling. |
Lin, Yi-Hsiung; Tsai, Wei-Chung; Chiu, Chien-Chih; Chi, Nai-Yu; Liu, Yi-Hsueh; Huang, Tien-Chi; Wu, |
|
Aug 1, 2024 |
7274 |
| Updates in Arrhythmia Management in Adult Congenital Heart Disease. |
Small, Adam J.; Dai, Matthew; Halpern, Dan G.; Tan, Reina Bianca |
Report |
Aug 1, 2024 |
9338 |
| Effects of SGLT2 Inhibitors on Cardiac Mechanics in Hispanic and Black Diabetic Patients. |
Moras, Errol; Shrivastav, Rishi; Gandhi, Kruti D.; Bandyopadhyay, Dhrubajyoti; Isath, Ameesh; Goel, |
Report |
Aug 1, 2024 |
6815 |
| Post-COVID Myocarditis in Patients with Primary Cardiomyopathies: Diagnosis, Clinical Course and Outcomes. |
Blagova, Olga; Lutokhina, Yulia; Kogan, Evgeniya; Savina, Polina; Aleksandrova, Svetlana; Zaklyazmin |
Report |
Aug 1, 2024 |
5868 |
| Beyond Blood Sugar: How Left Atrium Strain Predicts Cardiac Outcomes in Type 2 Diabetes. |
Benchea, Laura-Catalina; Anghel, Larisa; Zavoi, Alexandra; Chiuariu, Traian; Birgoan, Silviu-Gabriel |
Report |
Aug 1, 2024 |
7171 |
| Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular–Kidney–Metabolic Factors: SIMETAP-AF Study. |
Ruiz-García, Antonio; Serrano-Cumplido, Adalberto; Escobar-Cervantes, Carlos; Arranz-Martínez, Ezequ |
|
Aug 1, 2024 |
8985 |
| Mind the gap in kidney care: translating what we know into what we do. |
Luyckx, V.A.; Tuttle, K.R.; Abdellatif, D.; Correa-Rotter, R.; Fung, W.W.S.; Haris, A.; Hsiao, L.L.; |
Report |
Aug 1, 2024 |
7885 |
| Molecular Aspects of Cardiovascular Risk Factors. |
Xu, Shang-Zhong; Sathyapalan, Thozhukat |
|
Aug 1, 2024 |
3245 |
| Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis. |
Guo, Shangze; Tong, Yinghao; Li, Ting; Yang, Kexin; Gao, Wei; Peng, Fujun; Zou, Xiangyu |
|
Aug 1, 2024 |
9525 |
| Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients. |
Katsuyama, Hisayuki; Horinaka, Seiichi; Hakoshima, Mariko; Adachi, Hiroki; Yanai, Hidekatsu |
Report |
Aug 1, 2024 |
8817 |
| Heart failure isn't always as extreme as it may sound. |
Dr Anya Heywood |
|
Jul 22, 2024 |
476 |
| MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development. |
Khaznadar, Farah; Khaznadar, Omar; Petrovic, Ana; Hefer, Marija; Gjoni, Fabian; Gjoni, Stefan; Stein |
|
Jul 1, 2024 |
9312 |
| SGLT2 Inhibitors Empagliflozin and Canagliflozin Ameliorate Allergic Asthma Responses in Mice. |
Lee, Ye-Eul; Im, Dong-Soon |
|
Jul 1, 2024 |
5369 |
| Microvascular Dysfunction across the Spectrum of Heart Failure Pathology: Pathophysiology, Clinical Features and Therapeutic Implications. |
La Vecchia, Giulia; Fumarulo, Isabella; Caffè, Andrea; Chiatto, Mario; Montone, Rocco A.; Aspromonte |
|
Jul 1, 2024 |
8789 |
| Emergency CT Scans: Unveiling the Risks of Contrast-Associated Acute Kidney Injury. |
Sorgun, Omay; Karaali, Rezan; Arikan, Cüneyt; Kanter, Efe; Yurtsever, Güner |
Clinical report |
Jul 1, 2024 |
6023 |
| Supplementation with Highly Standardized Cranberry Extract Phytosome Achieved the Modulation of Urinary Tract Infection Episodes in Diabetic Postmenopausal Women Taking SGLT-2 Inhibitors: A RCT Study. |
Rondanelli, Mariangela; Mansueto, Francesca; Gasparri, Clara; Solerte, Sebastiano Bruno; Misiano, Pa |
Report |
Jul 1, 2024 |
5023 |
| Safety and Efficacy of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction: Multicentre Retrospective Study on Echocardiographic Parameters and Biomarkers of Heart Congestion. |
Battistoni, Ilaria; Pongetti, Giulia; Falchetti, Elena; Giannini, Irene; Olivieri, Roberto; Gioacchi |
Report |
Jun 1, 2024 |
5388 |
| Contemporary Use of Sodium Glucose Co-Transporter 2 Inhibitors in Hospitalized Heart Failure Patients: A “Real-World” Experience. |
Xanthopoulos, Andrew; Katsiadas, Nikolaos; Giamouzis, Grigorios; Vangelakou, Kleoniki; Balaskas, Dim |
Report |
Jun 1, 2024 |
6661 |
| Hypertension and Heart Failure: From Pathophysiology to Treatment. |
Gallo, Giovanna; Savoia, Carmine |
|
Jun 1, 2024 |
10546 |
| Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy. |
Karvaly, Gellert Balazs; Vásárhelyi, Barna |
|
Jun 1, 2024 |
3352 |
| Electrophysiological Effects of the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor Dapagliflozin on Human Cardiac Potassium Channels. |
Müller, Mara Elena; Petersenn, Finn; Hackbarth, Juline; Pfeiffer, Julia; Gampp, Heike; Frey, Norbert |
|
Jun 1, 2024 |
6239 |
| Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction. |
Asakura-Kinoshita, Maki; Masuda, Takahiro; Oka, Kentaro; Ohara, Ken; Miura, Marina; Morinari, Masato |
Report |
Jun 1, 2024 |
8359 |
| Guideline-Optimised Treatment in Heart Failure—Do Higher Doses Reduce Systemic Inflammation More Significantly? |
Arvunescu, Alexandru Mircea; Ionescu, Ruxandra Florentina; Dumitrescu, Silviu Ionel; Zaharia, Ondin; |
Report |
Jun 1, 2024 |
8990 |
| The Impact of the Withdrawal of SGLT2 Inhibitors on Clinical Outcomes in Patients with Heart Failure. |
Nakagaito, Masaki; Imamura, Teruhiko; Ushijima, Ryuichi; Nakamura, Makiko; Kinugawa, Koichiro |
Report |
Jun 1, 2024 |
5589 |
| Immune-Mediated Ocular Surface Disease in Diabetes Mellitus—Clinical Perspectives and Treatment: A Narrative Review. |
Ghenciu, Laura Andreea; Ha?egan, Ovidiu Alin; Bolintineanu, Sorin Lucian; Danila, Alexandra-Ioana; F |
|
Jun 1, 2024 |
10153 |
| Heart Failure with Mid-Range or Mildly Reduced Ejection Fraction in the Era of Sodium–Glucose Co-Transporter 2 Inhibitors: Do We Now Provide Better Care for the “Middle Child of HF”? Real-World Experience from a Single Clinical Centre. |
Vidak, Marin; Kursar, Jelena; Bodrožic Džakic Poljak, Tomislava; Letilovic, Tomislav; Catic, Jasmina |
|
Jun 1, 2024 |
6179 |
| Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial. |
Balleza Alejandri, Luis Ricardo; Grover Páez, Fernando; González Campos, Erick; Ramos Becerra, Carlo |
|
Jun 1, 2024 |
3867 |
| Sodium-Glucose Cotransporter Type 2 Inhibitors Use in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry. |
Guzmán-Carreras, Alicia; Vellisca-González, Andrea María; Molina-Puente, Juan Igor; García-Alonso, R |
Report |
Jun 1, 2024 |
6536 |
| Exogenous Melatonin Enhances Dihydrochalcone Accumulation in Lithocarpus litseifolius Leaves via Regulating Hormonal Crosstalk and Transcriptional Profiling. |
Zhang, Wenlong; Sun, Yuqi; Wang, Hongfeng; Xu, Mingfeng; He, Chunmei; Wang, Congcong; Yu, Yongli; Zh |
|
May 1, 2024 |
8026 |
| Dapagliflozin Improves Angiogenesis after Hindlimb Ischemia through the PI3K-Akt-eNOS Pathway. |
Han, Li; Ye, Guoxin; Su, Wenjing; Zhu, Yuankang; Wu, Wenqi; Hao, Liangshi; Gao, Jing; Li, Zhen; Liu, |
Report |
May 1, 2024 |
9805 |
| Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers. |
Trimarchi, Giancarlo; Teresi, Lucio; Licordari, Roberto; Pingitore, Alessandro; Pizzino, Fausto; Gri |
|
May 1, 2024 |
16500 |
| Effect of SGLT2-Inhibitors on Polygraphic Parameters in Elderly Patients Affected by Heart Failure, Type 2 Diabetes Mellitus, and Sleep Apnea. |
Armentaro, Giuseppe; Pelaia, Corrado; Condoleo, Valentino; Severini, Giandomenico; Crudo, Giulia; De |
Disease/Disorder overview |
May 1, 2024 |
7163 |
| The Congestion “Pandemic” in Acute Heart Failure Patients. |
Mocan, Daniela; Lala, Radu Ioan; Puschita, Maria; Pilat, Luminita; Darabantiu, Dan Alexandru; Pop-Mo |
|
May 1, 2024 |
11476 |
| Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS). |
D’Elia, John A.; Weinrauch, Larry A. |
|
May 1, 2024 |
8902 |
| Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease. |
Bonacchi, Giacomo; Rossi, Valentina Alice; Garofalo, Manuel; Mollace, Rocco; Uccello, Giuseppe; Pier |
|
May 1, 2024 |
13987 |
| Unexpectedly Rapid Onset of Severe Sarcopenia in an Elderly Diabetic Man following SGLT2i Administration: A Case Report. |
Czarnecka, Paulina; Czarnecka, Kinga; Tronina, Olga |
Report |
May 1, 2024 |
4471 |
| Differential Modulation of Catecholamine and Adipokine Secretion by the Short Chain Fatty Acid Receptor FFAR3 and a[sub.2]-Adrenergic Receptors in PC12 Cells. |
Nagliya, Deepika; Baggio Lopez, Teresa; Del Calvo, Giselle; Stoicovy, Renee A.; Borges, Jordana I.; |
|
May 1, 2024 |
5609 |
| Early initiation of Dapagliflozin and its effect on health related quality of life in acute heart failure: a randomised controlled trial. |
|
Report |
Apr 30, 2024 |
2204 |
| Characteristics, Risk Factors, and Outcomes in Acute Kidney Injury Patients: A Retrospective Cross-Sectional Study, Palestine. |
Damin Abukhalil, Abdallah; Alyazouri, Haya; Alsheikh, Reem; Kahla, Hadeel; Mousa, Minna; Ladadweh, H |
Report |
Apr 8, 2024 |
7592 |
| Mind the Gap in Kidney Care: Translating What We Know into what we do. |
Luyckx, Valerie A.; Tuttle, Katherine R.; Abdellatif, Dina; Correa-Rotter, Ricardo; Fung, Winston W. |
|
Apr 1, 2024 |
14697 |
| Non-Pharmacological Treatment of Heart Failure—From Physical Activity to Electrical Therapies: A Literature Review. |
Scarà, Antonio; Palamà, Zefferino; Robles, Antonio Gianluca; Dei, Lorenzo-Lupo; Borrelli, Alessio; Z |
|
Apr 1, 2024 |
9139 |
| Novel Medical Treatments and Devices for the Management of Heart Failure with Reduced Ejection Fraction. |
Alfieri, Michele; Bruscoli, Filippo; Di Vito, Luca; Di Giusto, Federico; Scalone, Giancarla; Marches |
|
Apr 1, 2024 |
10486 |
| Triptolide Administration Alters Immune Responses to Mitigate Insulin Resistance in Obese States. |
Grodsky, Lyudmila; Wilson, Mickey; Rathinasabapathy, Thirumurugan; Komarnytsky, Slavko |
Report |
Apr 1, 2024 |
6437 |
| Association of NT-proBNP and sST2 with Left Ventricular Ejection Fraction and Oxidative Stress in Patients with Stable Dilated Cardiomyopathy. |
Lazar-Poloczek, Elzbieta; Romuk, Ewa; Jachec, Wojciech; Wróbel-Nowicka, Karolina; Swietek, Agata; Wo |
|
Apr 1, 2024 |
8583 |
| Improving Kidney Disease Care: One Giant Leap for Nephrology. |
Provenzano, Michele; Hu, Lilio; Tringali, Edoardo; Senatore, Massimo; Talarico, Roberta; Di Dio, Mic |
|
Apr 1, 2024 |
11458 |
| Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure. |
Marinescu, Mihai Cristian; Oprea, Violeta Diana; Munteanu, Sorina Nicoleta; Nechita, Aurel; Tutunaru |
|
Apr 1, 2024 |
7612 |
| Preventive and Therapeutic Effects of Crocetin in Rats with Heart Failure. |
Ma, Renqiang; Li, Sijia; Mo, Qingmei; Chen, Xiaojuan; Liang, Yan; Hu, Tao; Hu, Hui; He, Bao; Li, Ren |
Report |
Apr 1, 2024 |
10102 |
| A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects. |
Jiang, Xu; Yu, Kyung-Sang; Nam, Dong Hyuk; Oh, Jaeseong |
Report |
Apr 1, 2024 |
5751 |
| Acute Anterior Choroidal Artery Territory Infarction: A Case Series Report. |
Tsika, Antonia; Stamati, Polyxeni; Tsouris, Zisis; Provatas, Antonios; Papa, Alexandra; Tsimoulis, D |
Report |
Apr 1, 2024 |
4124 |
| Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial. |
Bonilha, Isabella; Gomes, Érica Ivana Lázaro; Carmo, Helison R. P.; Breder, Ikaro; Barreto, Joaquim; |
|
Apr 1, 2024 |
4134 |
| Contrast-Induced Acute Kidney Injury in Patients with Heart Failure on Sodium–Glucose Cotransporter-2 Inhibitors Undergoing Radiocontrast Agent Invasive Procedures: A Propensity-Matched Analysis. |
Nardi, Giulia; Marchi, Enrico; Allinovi, Marco; Lugli, Gianmarco; Biagiotti, Lucrezia; Di Muro, Fran |
Report |
Apr 1, 2024 |
6278 |
| Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium. |
Kourek, Christos; Briasoulis, Alexandros; Papamichail, Adamantia; Xanthopoulos, Andrew; Tsougos, Eli |
Disease/Disorder overview |
Mar 1, 2024 |
10143 |
| The Role of Sodium-Glucose Co-Transporter-2 Inhibitors on Diuretic Resistance in Heart Failure. |
Stachteas, Panagiotis; Nasoufidou, Athina; Patoulias, Dimitrios; Karakasis, Paschalis; Karagiannidis |
|
Mar 1, 2024 |
9169 |
| Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension. |
Sykora, Matus; Szeiffova Bacova, Barbara; Andelova, Katarina; Egan Benova, Tamara; Martiskova, Adria |
|
Mar 1, 2024 |
11866 |
| Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario. |
Melero, Rosa; Torroba-Sanz, Beatriz; Goicoechea, Marian; Sousa-Casasnovas, Iago; Barrio, Jose María; |
|
Mar 1, 2024 |
6900 |
| Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure with Malnutrition, Frailty, Sarcopenia, or Cachexia. |
Horiuchi, Yu; Asami, Masahiko; Yahagi, Kazuyuki; Oshima, Asahi; Gonda, Yuki; Yoshiura, Daiki; Komiya |
Report |
Mar 1, 2024 |
5888 |
| Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis. |
Kleinjan, Jan P.; Blom, Justin; van Beek, André P.; Bouma, Hjalmar R.; van Dijk, Peter R. |
Clinical report |
Mar 1, 2024 |
3975 |
| Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY[sub.3-36], and Empagliflozin on Early MASLD in Diet-Induced Obese Rats. |
Kloock, Simon; Haerting, Niklas; Herzog, Gloria; Oertel, Marie; Geiger, Niklas; Geier, Andreas; Sequ |
|
Mar 1, 2024 |
7512 |
| Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models. |
Castoldi, Giovanna; Carletti, Raffaella; Barzaghi, Francesca; Meani, Michela; Zatti, Giovanni; Perse |
Report |
Mar 1, 2024 |
6960 |
| Digital Technology Applications in the Management of Adverse Drug Reactions: Bibliometric Analysis. |
Litvinova, Olena; Yeung, Andy Wai Kan; Hammerle, Fabian Peter; Mickael, Michel-Edwar; Matin, Maima; |
Report |
Mar 1, 2024 |
9401 |
| Investigation of the Expression of CYP3A4 in Diabetic Rats in Xenobiotic Metabolism. |
Guven, Naile Merve; Karaomerlioglu, Irem; Inan, Ebru Arioglu; Eke, Benay Can |
Report |
Feb 1, 2024 |
4605 |
| Gender Effect on Clinical Profiles, Pharmacological Treatments and Prognosis in Patients Hospitalized for Heart Failure. |
Fazzini, Luca; Casati, Mattia; Martis, Alessandro; Perra, Ferdinando; Rubiolo, Paolo; Deidda, Martin |
Report |
Feb 1, 2024 |
8422 |
| Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products. |
Ding, Yuyang; Xue, Xiaoqian |
|
Feb 1, 2024 |
9471 |
| MCC950 Ameliorates Diabetic Muscle Atrophy in Mice by Inhibition of Pyroptosis and Its Synergistic Effect with Aerobic Exercise. |
Yan, Xiaoyu; Fu, Pengyu; Zhang, Yimin; Ling, Dongmei; Reynolds, Lewis; Hua, Weicheng; Wang, Zhiyuan; |
|
Feb 1, 2024 |
10535 |
| CoQ[sub.10] and Mitochondrial Dysfunction in Alzheimer’s Disease. |
Fišar, Zdenek; Hroudová, Jana |
|
Feb 1, 2024 |
12741 |
| The Han:SPRD Rat: A Preclinical Model of Polycystic Kidney Disease. |
Kofotolios, Ioannis; Bonios, Michael J.; Adamopoulos, Markos; Mourouzis, Iordanis; Filippatos, Geras |
|
Feb 1, 2024 |
8220 |
| Editorial for the Special Issue: Pathophysiology of Chronic Kidney Disease and Its Complications. |
Oe, Yuji |
Editorial |
Feb 1, 2024 |
1592 |
| Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model. |
Târtea, Georgica; Popa-Wagner, Aurel; Sfredel, Veronica; Mitran, Smaranda Ioana; Dan, Alexandra Olte |
|
Feb 1, 2024 |
8713 |
| An Update on Current Therapeutic Options in IgA Nephropathy. |
Lim, Regina Shaoying; Yeo, See Cheng; Barratt, Jonathan; Rizk, Dana V. |
Report |
Feb 1, 2024 |
9519 |
| Sodium-Glucose Co-Transporter 2 Inhibitors: Mechanism of Action and Efficacy in Non-Diabetic Kidney Disease from Bench to Bed-Side. |
Abdelrahman, Aly M.; Awad, Alaa S.; Abdel-Rahman, Emaad M. |
Report |
Feb 1, 2024 |
9386 |
| Sex Differences in Cardiac and Clinical Phenotypes and Their Relation to Outcomes in Patients with Heart Failure. |
Kawai, Akane; Nagatomo, Yuji; Yukino-Iwashita, Midori; Nakazawa, Ryota; Yumita, Yusuke; Taruoka, Aki |
|
Feb 1, 2024 |
9443 |
| Comparison of the efficacy of combining left bundle branch pacing with either sacubitril/valsartan or enalapril in the treatment of chronic heart failure: A retrospective observational analysis. |
Shengping Wang, Yongsheng Feng, Xiangyang Sun, Hualiang Gou and Yong Guo |
|
Jan 25, 2024 |
2964 |
| Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabetic Mice with Nephropathy. |
Zhang, Zeng; Fu, Xiaodong; Zhou, Fengzhu; Zhang, Duanchun; Xu, Yanqiu; Fan, Zhaohua; Wen, Shimei |
|
Jan 20, 2024 |
11197 |
| Qatar-based researcher highlights effective DKD treatment options. |
|
|
Jan 19, 2024 |
528 |
| A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study). |
Kim, Hae Jin; Noh, Jung Hyun; Moon, Min Kyong; Choi, Sung Hee; Ko, Seung-Hyun; Rhee, Eun-Jung; Hur, |
Clinical report |
Jan 5, 2024 |
6076 |
| Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis—A Clinical Feasibility Study. |
Steinhardt, Maximilian J.; Cejka, Vladimir; Chen, Mengmeng; Bäuerlein, Sabrina; Schäfer, Julia; Adra |
Report |
Jan 1, 2024 |
4790 |
| Synthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism. |
Li, Jinsheng; Hou, Xueli; Xiao, Jinlong; Zhu, Li; Deng, Yujie; Li, Ziyi; Zhao, Zijian; Luo, Zhenghon |
|
Jan 1, 2024 |
6021 |
| Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities. |
Patera, Francesco; Gatticchi, Leonardo; Cellini, Barbara; Chiasserini, Davide; Reboldi, Gianpaolo |
Report |
Jan 1, 2024 |
10004 |
| Decongestion in Acute Heart Failure—Time to Rethink and Standardize Current Clinical Practice? |
Bilgeri, Valentin; Spitaler, Philipp; Puelacher, Christian; Messner, Moritz; Adukauskaite, Agne; Bar |
|
Jan 1, 2024 |
8857 |
| The Effect of Sodium–Glucose Cotransporter-2 Inhibitors on COVID-19 Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study Using the Common Data Model. |
Lim, Kyoung Ree; Chun, Kwang Jin; Kim, Bum Sung; Lee, Seunghwa |
Report |
Jan 1, 2024 |
5077 |
| Pulmonary Vascular Resistance to Predict Right Heart Failure in Patients Undergoing Left Ventricular Assist Device Implantation. |
Schramm, René; Kirchner, Johannes; Ibrahim, Mohamad; Rojas, Sebastian V.; Morshuis, Michiel; Rudolph |
Report |
Jan 1, 2024 |
4977 |
| The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword? |
Naito, Ayami; Nagatomo, Yuji; Kawai, Akane; Yukino-Iwashita, Midori; Nakazawa, Ryota; Taruoka, Akira |
|
Jan 1, 2024 |
8580 |
| Mortality in IgA Nephropathy: A Long-Term Follow-Up of an Eastern European Cohort. |
?tefan, Gabriel; Zugravu, Adrian; Stancu, Simona |
|
Jan 1, 2024 |
4933 |
| Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights. |
D’Amato, Andrea; Prosperi, Silvia; Severino, Paolo; Myftari, Vincenzo; Labbro Francia, Aurora; Cesti |
|
Jan 1, 2024 |
12585 |
| Oral Cardiac Drug–Gut Microbiota Interaction in Chronic Heart Failure Patients: An Emerging Association. |
Paraskevaidis, Ioannis; Briasoulis, Alexandros; Tsougos, Elias |
|
Jan 1, 2024 |
8134 |
| Diabetes and the prostate. |
Sanjay Kalra, Nitin Kapoor and Saurabh Arora |
Report |
Dec 21, 2023 |
927 |
| Dapagliflozin: a potential lifesaver for "heart failure patients with mildly reduced or preserved ejection fraction" in the world. |
Faizan Shafqat Ali Bijarani, Ahsan Nazeer and Bisma Shaikh |
|
Dec 7, 2023 |
464 |
| A Transcriptome Array-Based Approach to Link SGLT-2 and Intrarenal Complement C5 Synthesis in Diabetic Nephropathy. |
Korsten, Peter; Tampe, Björn |
|
Dec 1, 2023 |
4028 |
| Generic drug makers continue to earn approvals. |
|
|
Dec 1, 2023 |
752 |
| Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide Exposure. |
Guven, Alper Tuna; Ozdede, Murat; Sener, Yusuf Ziya |
Report |
Dec 1, 2023 |
3903 |
| Association between Neck Circumference and Chronic Kidney Disease in Korean Adults in the 2019–2021 Korea National Health and Nutrition Examination Survey. |
Yoon, Youngmin; Kim, Yoo-min; Lee, Somin; Shin, Byung-Chul; Kim, Hyun-Lee; Chung, Jong-Hoon; Son, Mi |
Survey |
Dec 1, 2023 |
7394 |
| In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. |
Siddique, Muhammad Hamid; Bukhari, Sidra; Khan, Inam Ullah; Essa, Asiya; Ali, Zain; Sabir, Usama; Ay |
Report |
Dec 1, 2023 |
8835 |
| IgA Nephropathy: Beyond the Half-Century. |
Shimizu, Yoshio; Tomino, Yasuhiko; Suzuki, Yusuke |
Report |
Dec 1, 2023 |
10821 |
| Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists. |
Myasoedova, Veronika A.; Bozzi, Michele; Valerio, Vincenza; Moschetta, Donato; Massaiu, Ilaria; Rusc |
|
Dec 1, 2023 |
10533 |
| Association between intestinal microflora and renal function in patients with chronic renal failure: A case-control analysis. |
Haixia Chen, Xiaoxiao Xie and Shuming Tang |
|
Nov 25, 2023 |
2997 |
| With An Inexpensive Pill, Kidney Disease-Related Deaths Could Be Reduced. |
|
|
Nov 18, 2023 |
368 |
| 2023 World Diabetes Day: Patients groan over high cost of medications. |
|
|
Nov 14, 2023 |
734 |
| AstraZeneca: Zibotentan/dapagliflozin combination shows albuminuria reduction. |
|
|
Nov 3, 2023 |
228 |
| Dapagliflozin Mitigated Elevated Disomic and Diploid Sperm in a Mouse Model of Diabetes and Recover the Disrupted Ogg1, Parp1, and P53 Gene Expression. |
Albekairi, Norah A.; Al-Hamamah, Mohammed A.; Alshamrani, Ali A.; Attia, Mohamed S. M.; Nadeem, Ahme |
|
Nov 1, 2023 |
7099 |
| Targeting Autophagy, Apoptosis, and Oxidative Perturbations with Dapagliflozin Mitigates Cadmium-Induced Cognitive Dysfunction in Rats. |
Arab, Hany H.; Eid, Ahmed H.; Alsufyani, Shuruq E.; Ashour, Ahmed M.; El-Sheikh, Azza A. K.; Darwish |
|
Nov 1, 2023 |
10059 |
| Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD). |
Choubey, Mayank; Tirumalasetty, Munichandra B.; Bora, Nalini S.; Bora, Puran S. |
|
Nov 1, 2023 |
8811 |
| Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron? |
Evangelidis, Paschalis; Venou, Theodora-Maria; Fani, Barmpageorgopoulou; Vlachaki, Efthymia; Gavriil |
|
Nov 1, 2023 |
10763 |
| Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent. |
Chinyama, Harold A.; Wei, Li; Mokgautsi, Ntlotlang; Lawal, Bashir; Wu, Alexander T. H.; Huang, Hsu-S |
|
Nov 1, 2023 |
8104 |
| New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events. |
Lavalle, Carlo; Di Lullo, Luca; Jabbour, Jean Pierre; Palombi, Marta; Trivigno, Sara; Mariani, Marco |
|
Nov 1, 2023 |
8584 |
| Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study. |
Saijo, Yuto; Okada, Hiroshi; Hata, Shinnosuke; Nakajima, Hanako; Kitagawa, Nobuko; Okamura, Takuro; |
Report |
Nov 1, 2023 |
5974 |
| Diabetes Mellitus in Acute Coronary Syndrome. |
Stampouloglou, Panagiota K.; Anastasiou, Artemis; Bletsa, Evanthia; Lygkoni, Stavroula; Chouzouri, F |
Report |
Nov 1, 2023 |
12234 |
| A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence. |
Mathur, Mohit; Chan, Tak Mao; Oh, Kook-Hwan; Kooienga, Laura; Zhuo, Min; Pinto, Cibele S.; Chacko, B |
Report |
Nov 1, 2023 |
9938 |
| The Role of Autophagy in Type 2 Diabetic Kidney Disease Management. |
Tseng, Che-Hao; Shah, Kavya M.; Chiu, I-Jen; Hsiao, Li-Li |
Report |
Nov 1, 2023 |
9689 |
| Immunolocalization of Sphingolipid Catabolism Enzymes along the Nephron: Novel Early Urinary Biomarkers of Renal Damage. |
Franco, Martha; Cano-Martínez, Agustina; Ramos-Godínez, María del Pilar; López-Marure, Rebeca; Donis |
|
Nov 1, 2023 |
5685 |
| Investigating the Cardiovascular Benefits of Dapagliflozin: Vasodilatory Effect on Isolated Rat Coronary Arteries. |
Choi, Sooyeon; Haam, Chae Eun; Byeon, Seonhee; Oh, Eun Yi; Choi, Soo-Kyoung; Lee, Young-Ho |
|
Nov 1, 2023 |
6170 |
| Changes in Left Ventricular Ejection Fraction and Clinical Trajectories of Transthyretin Cardiac Amyloidosis with Systolic Dysfunction. |
Saef, Joshua; Martyn, Trejeeve; Ray Dey, Anusha; Khedraki, Rola; Ives, Lauren; Collier, Patrick; Jab |
Report |
Nov 1, 2023 |
3702 |
| SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role? |
Zimmermann, Paul; Sourij, Harald; Aberer, Felix; Rilstone, Sian; Schierbauer, Janis; Moser, Othmar |
|
Nov 1, 2023 |
6387 |
| The effect of Dapagliflozin on renal functions in hospitalized patients with Acute Heart Failure. |
Syedah Fauzia Fatima Gilani, Shabana Ali, Muhammad Bilal Siddique, Kulsoom Farhat, Mudassar Noor and |
|
Oct 8, 2023 |
2638 |
| Acute Coronary Syndrome with Non-Obstructive Plaque on Angiography and Features of Vulnerable Plaque on Intracoronary Optical Coherence Tomography. |
Dall’Orto, Clarissa Campo; Ferreira Lopes, Rubens Pierry; Eurípedes, Lara Vilela; Pinto Filho, Gilva |
|
Oct 1, 2023 |
3791 |
| Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction. |
Alcidi, Gianmarco; Pugliese, Rosanna; Ioannoni, Sara; Romano, Matteo; Palmieri, Gianpaolo; Tabella, |
|
Oct 1, 2023 |
5170 |
| Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies. |
Balsa, André; Adão, Rui; Brás-Silva, Carmen |
|
Oct 1, 2023 |
8158 |
| The Diagnostic Value of Trace Metal Concentrations in Hair in Carotid Artery Disease. |
Olasinska-Wisniewska, Anna; Urbanowicz, Tomasz; Hanc, Anetta; Tomczak, Jolanta; Begier-Krasinska, Be |
Report |
Oct 1, 2023 |
6606 |
| Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin. |
Escobar, Carlos; Pascual-Figal, Domingo; Manzano, Luis; Nuñez, Julio; Camafort, Miguel |
|
Oct 1, 2023 |
12959 |
| Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study. |
Nakhleh, Afif; Othman, Areen; Masri, Amin; Zloczower, Moshe; Zolotov, Sagit; Shehadeh, Naim |
Report |
Oct 1, 2023 |
4584 |
| A Current Landscape on Alport Syndrome Cases: Characterization, Therapy and Management Perspectives. |
Mahrous, Nahed N.; Jamous, Yahya F.; Almatrafi, Ahmad M.; Fallatah, Deema I.; Theyab, Abdulrahman; A |
|
Oct 1, 2023 |
6719 |
| Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease—A Retrospective Single-Arm Case Series Study. |
Morioka, Fumiyuki; Nakatani, Shinya; Uedono, Hideki; Tsuda, Akihiro; Mori, Katsuhito; Emoto, Masanor |
Report |
Oct 1, 2023 |
7752 |
| Dapagliflozin Improved Cardiac Function and Structure in Diabetic Patients with Preserved Ejection Fraction: Results of a Single Centre, Observational Prospective Study. |
Cortés, Marcelino; Lorenzo, Oscar; Lumpuy-Castillo, Jairo; Martínez-Albaladejo, Sacramento; Taibo-Ur |
Report |
Oct 1, 2023 |
7416 |
| Early detection key to treating chronic kidney disease. |
|
|
Sep 27, 2023 |
758 |
| The Role of Oxidative Stress in Kidney Injury. |
Piko, Nejc; Bevc, Sebastjan; Hojs, Radovan; Ekart, Robert |
|
Sep 1, 2023 |
7967 |
| Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases. |
Pallio, Giovanni |
Editorial |
Sep 1, 2023 |
3030 |
| Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy. |
Ye, Muyao; Yang, Ming; Dai, Wenni; Li, Hao; Zhou, Xun; Chen, Yinyin; He, Liyu |
Report |
Sep 1, 2023 |
8578 |
| The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target. |
Wolowiec, Anna; Wolowiec, Lukasz; Grzesk, Grzegorz; Jasniak, Albert; Osiak, Joanna; Husejko, Jakub; |
|
Sep 1, 2023 |
11780 |
| Impact of Impaired Kidney Function on Arrhythmia-Promoting Cardiac Ion Channel Regulation. |
Sinha, Frederick; Schweda, Frank; Maier, Lars S.; Wagner, Stefan |
|
Sep 1, 2023 |
8510 |
| Heart Failure in Patients with Chronic Kidney Disease. |
Xanthopoulos, Andrew; Papamichail, Adamantia; Briasoulis, Alexandros; Loritis, Konstantinos; Bouraza |
Report |
Sep 1, 2023 |
10741 |
| Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer’s Disease in Rats. |
Abd Elmaaboud, Maaly A.; Estfanous, Remon S.; Atef, Aliaa; Kabel, Ahmed M.; Alnemari, Khalid A.; Nag |
Report |
Sep 1, 2023 |
11026 |
| Nonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease. |
Shah, Monarch; Awad, Alaa S.; Abdel-Rahman, Emaad M |
|
Sep 1, 2023 |
5677 |
| Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes. |
Bang, Jisun; Lee, Sang Ah; Koh, Gwanpyo; Yoo, Soyeon |
Report |
Sep 1, 2023 |
5452 |
| Targeting Collagen Pathways as an HFpEF Therapeutic Strategy. |
Bonanni, Alice; Vinci, Ramona; d’Aiello, Alessia; Grimaldi, Maria Chiara; Di Sario, Marianna; Tarqui |
Report |
Sep 1, 2023 |
5632 |
| Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis. |
Asrial, An Aldia; Reviono, Reviono; Soetrisno, Soetrisno; Setianto, Budi Yuli; Widyaningsih, Vitri; |
Report |
Sep 1, 2023 |
7535 |
| Add-On Therapy of Dapagliflozin to Metformin in Patients with Diabetes Mellitus Type-2; Efficacy and Renal Safety. |
Benish Adil, Arshad Rabbani, Imran Arshad, Sualeha Ahmed and Muhammad Ali Khalid |
|
Aug 31, 2023 |
2347 |
| Hypertriglyceridaemia induced pancreatitis management: A case report. |
Mufti, Aisha Kulsoom; Ullah, Naqeeb; Hayat, Muhammad; Khan, Muhammad Aimal |
Clinical report |
Aug 31, 2023 |
1932 |
| AstraZeneca to present 19 abstracts at upcoming ESC Congress. |
|
|
Aug 21, 2023 |
220 |
| Extracellular Vesicles: Investigating the Pathophysiology of Diabetes-Associated Hypertension and Diabetic Nephropathy. |
Alli, Abdel A. |
|
Aug 1, 2023 |
8237 |
| Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure. |
Xanthopoulos, Andrew; Katsiadas, Nikolaos; Skoularigkis, Spyridon; Magouliotis, Dimitrios E.; Skopel |
Report |
Aug 1, 2023 |
6831 |
| Renal Perfusion, Oxygenation and Metabolism: The Role of Imaging. |
Päivärinta, Johanna; Anastasiou, Ioanna A.; Koivuviita, Niina; Sharma, Kanishka; Nuutila, Pirjo; Fer |
Report |
Aug 1, 2023 |
8059 |
| Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience. |
Tabella, Erika; Correale, Michele; Alcidi, Gianmarco; Pugliese, Rosanna; Ioannoni, Sara; Romano, Mat |
Drug overview |
Aug 1, 2023 |
5704 |
| Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment. |
Theofilis, Panagiotis; Oikonomou, Evangelos; Chasikidis, Christos; Tsioufis, Konstantinos; Tousoulis |
Report |
Aug 1, 2023 |
8613 |
| Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases. |
Stamatiades, G. A.; D'Silva, P.; Elahee, M.; Viana, G. M.; Sideri-Gugger, A.; Majumdar, S. K. |
|
Jul 4, 2023 |
5102 |
| Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors? |
De La Flor, José C.; Villa, Daniel; Cruzado, Leónidas; Apaza, Jacqueline; Valga, Francisco; Zamora, |
|
Jul 1, 2023 |
8193 |
| Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot. |
Samsky, Marc D.; Leverty, Renee; Gray, James M.; Davis, Alexandra; Fisher, Brett; Govil, Ashul; Stan |
Report |
Jul 1, 2023 |
4717 |
| Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven? |
Heyman, Samuel N.; Abassi, Zaid |
Viewpoint essay |
Jul 1, 2023 |
2470 |
| Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels. |
Schwertheim, Suzan; Alhardan, Malek; Manka, Paul P.; Sowa, Jan-Peter; Canbay, Ali; Schmidt, Hartmut |
|
Jul 1, 2023 |
10334 |
| Stimulation of Autophagy by Dapagliflozin Mitigates Cadmium-Induced Testicular Dysfunction in Rats: The Role of AMPK/mTOR and SIRT1/Nrf2/HO-1 Pathways. |
Arab, Hany H.; Fikry, Ebtehal Mohammad; Alsufyani, Shuruq E.; Ashour, Ahmed M.; El-Sheikh, Azza A. K |
Report |
Jul 1, 2023 |
9796 |
| The Effect of Additional Treatment with Empagliflozin or Semaglutide on Endothelial Function and Arterial Stiffness in Subjects with Type 1 Diabetes Mellitus—ENDIS Study. |
Navodnik, Maja Preložnik; Janež, Andrej; Žuran, Ivan |
|
Jul 1, 2023 |
9558 |
| A review of the expanding applications of SGLT2 inhibitors in chronic kidney disease and heart disease. |
Meng, Yuki; Battistella, Marisa |
Drug overview |
Jul 1, 2023 |
4124 |
| A review of the expanding applications of SGLT2 inhibitors in chronic kidney disease and heart disease. |
Meng, Yuki; Battistella, Marisa |
|
Jul 1, 2023 |
473 |
| Comparison of Extraglycemic effects of Dapagliflozin and Empagliflozin. |
Haroon Aziz, Mudassar Noor, Bilal Ahmad, Shabana Ali, Kulsoom Farhat and Fuad Ahmad Siddiqi |
|
Jun 30, 2023 |
2252 |
| The Prevalence of Severely Increased Albuminuria in the Type 2 Diabetes Population with Chronic Kidney Disease of Low Socioeconomic Status in San Juan: A Population in Need of Improved Accessibility to Disease-Modifying Therapy. |
Irizarry-Villafane, Gabriel I.; Gonzalez-Bossolo, Alex |
|
Jun 1, 2023 |
3949 |
| A COVID-19 Diagnosis Like an Avalanche Triggers a Series of Adverse Events but Saves a Life in the End. |
Iwanski, Mateusz; Sokolowska, Aldona; Wanczura, Piotr; Filipowska, Justyna; Styczkiewicz, Katarzyna |
Report |
Jun 1, 2023 |
3585 |
| Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets. |
Piccirillo, Francesco; Mastroberardino, Sara; Nusca, Annunziata; Frau, Lorenzo; Guarino, Lorenzo; Na |
|
Jun 1, 2023 |
12470 |
| Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation. |
Castoldi, Giovanna; Carletti, Raffaella; Ippolito, Silvia; Colzani, Massimiliano; Pelucchi, Sara; Ze |
|
Jun 1, 2023 |
5442 |
| Making Sense of Composite Endpoints in Clinical Research. |
Baracaldo-Santamaría, Daniela; Feliciano-Alfonso, John Edwin; Ramirez-Grueso, Raul; Rojas-Rodríguez, |
Report |
Jun 1, 2023 |
8982 |
| Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study. |
Shinozaki, Satoshi; Tahara, Toshiyuki; Miura, Kouichi; Lefor, Alan Kawarai; Yamamoto, Hironori |
Report |
Jun 1, 2023 |
6814 |
| The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure. |
Petho, Ákos Géza; Tapolyai, Mihály; Browne, Maria; Fülöp, Tibor; Orosz, Petronella; Szabó, Réka P. |
Report |
Jun 1, 2023 |
7825 |
| The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. |
Bica, Ioana-Cristina; Stoica, Roxana Adriana; Salmen, Teodor; Janež, Andrej; Volcanšek, Špela; Popov |
|
Jun 1, 2023 |
8483 |
| Significance of Endothelial Dysfunction Amelioration for Sodium–Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients. |
Yanai, Hidekatsu; Adachi, Hiroki; Hakoshima, Mariko; Katsuyama, Hisayuki |
Report |
Jun 1, 2023 |
12707 |
| Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds. |
Kosmalski, Marcin; Frankowski, Rafal; Deska, Kacper; Rózycka-Kosmalska, Monika; Pietras, Tadeusz |
Report |
Jun 1, 2023 |
24688 |
| Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level. |
Alanazi, Wael A.; Alharbi, Turki; El-Nagar, Doaa M.; Albogami, Abdullah M.; Alswayyed, Mohammed |
|
Jun 1, 2023 |
7326 |
| Avoiding Dehydration: Water, some foods, and other beverages contribute to keeping your body healthy and well hydrated. |
|
|
May 23, 2023 |
687 |
| Renoprotective Effect of Thai Patients with Type 2 Diabetes Mellitus Treated with SGLT-2 Inhibitors versus DPP-4 Inhibitors: A Real-World Observational Study. |
Chanawong, Apichaya; Uitrakul, Suriyon; Incomenoy, Supatcha; Poonchuay, Natnicha |
Report |
May 15, 2023 |
5915 |
| Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol. |
Battaglia, Yuri; Bulighin, Francesca; Zerbinati, Luigi; Vitturi, Nicola; Marchi, Giacomo; Carraro, G |
Report |
May 1, 2023 |
3484 |
| SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century? |
Kounatidis, Dimitris; Vallianou, Natalia; Evangelopoulos, Angelos; Vlahodimitris, Ioannis; Grivakou, |
|
May 1, 2023 |
9532 |
| Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism. |
Samman, Waad A.; Selim, Salma M.; El Fayoumi, Hassan M.; El-Sayed, Norhan M.; Mehanna, Eman T.; Haze |
Report |
May 1, 2023 |
10532 |
| New American Diabetes Association Guidelines on Chronic Kidney Disease Related to Diabetes. |
Chetan, Daniela |
|
May 1, 2023 |
1170 |
| Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes. |
Ma, Zijun; Jin, Kaiqin; Yue, Mengmeng; Chen, Xin; Chen, Jun |
|
Apr 15, 2023 |
6297 |
| Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies. |
Kang, So-Jin; Kim, Joo-Eun |
Report |
Apr 1, 2023 |
13939 |
| Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report. |
Tian, Yan; Hu, Weiting; Yan, Qun; Feng, Bo |
|
Apr 1, 2023 |
3920 |
| Raising Awareness About Kidney Disease: Your kidneys should be checked at your annual exam; often, simple tests can reveal if your kidney function is impaired. |
|
|
Mar 29, 2023 |
812 |
| Health officials decry diabetes drugs stock-outs. |
|
|
Mar 8, 2023 |
514 |
| Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure. |
Nakagaito, Masaki; Imamura, Teruhiko; Ushijima, Ryuichi; Nakamura, Makiko; Kinugawa, Koichiro |
Report |
Mar 1, 2023 |
5070 |
| Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure. |
Ng, Mei Li; Ang, Xu; Yap, Kwan Yi; Ng, Jun Jie; Goh, Eugene Chen Howe; Khoo, Benjamin Bing Jie; Rich |
Report |
Mar 1, 2023 |
22475 |
| SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism. |
Dia, Batoul; Alkhansa, Sahar; Njeim, Rachel; Al Moussawi, Sarah; Farhat, Theresa; Haddad, Antony; Ri |
Report |
Mar 1, 2023 |
9978 |
| Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors Use among Heart Failure Patients and the Role of Pharmacists in Early Initiation of Therapy. |
Aldhaeefi, Mohammed; Beers, Brandon; Shah, Jenny; Rizi, Saba Saeidi; Rungkitwattanakul, Dhakrit; Nim |
Report |
Mar 1, 2023 |
6292 |
| A Rare Single Case of COVID-19-Induced Acute Myocarditis and Encephalopathy Presenting Simultaneously. |
Saeedullah, Usman; Abbas, Anas M.; Ward, Caitlin; Bayya, Maha; Bhandari, Jenish; Abbas, Araf M.; DeL |
Clinical report |
Feb 1, 2023 |
4563 |
| The (Poly)phenol-Carbohydrate Combination for Diabetes: Where Do We Stand? |
de Matos, Ana Marta; Menezes, Regina |
Report |
Feb 1, 2023 |
4109 |
| The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure. |
Berezin, Alexander A.; Obradovic, Zeljko; Fushtey, Ivan M.; Berezina, Tetiana A.; Novikov, Evgen V.; |
Report |
Feb 1, 2023 |
9633 |
| SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug? |
Chan, Jonathan C. H.; Chan, Michael C. Y. |
Report |
Feb 1, 2023 |
7030 |
| A-fib Risk Lower with Newer Diabetes Medications. |
|
|
Feb 1, 2023 |
172 |
| A new role of SGLT-2 - treatment of IgA-nephropathy? |
|
|
Jan 31, 2023 |
586 |
| Practice Patterns in Fournier’s Gangrene in Europe and Implications for a Prospective Registry Study. |
Schneidewind, Laila; Kiss, Bernhard; Stangl, Fabian P.; Tandogdu, Zafer; Wagenlehner, Florian M. E.; |
Clinical report |
Jan 1, 2023 |
4551 |
| Anemoside B4 Exerts Hypoglycemic Effect by Regulating the Expression of GLUT4 in HFD/STZ Rats. |
Gong, Qin; Yin, Jilei; Wang, Mulan; Zha, Chengliang; Yu, Dong; Yang, Shilin; Feng, Yulin; Li, Jun; D |
Report |
Jan 1, 2023 |
8248 |
| SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol. |
Pawlos, Agnieszka; Broncel, Marlena; Wozniak, Ewelina; Markiewicz, Lukasz; Piastowska-Ciesielska, Ag |
Report |
Jan 1, 2023 |
5469 |
| Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study. |
Caturano, Alfredo; Galiero, Raffaele; Loffredo, Giuseppe; Vetrano, Erica; Medicamento, Giulia; Acier |
Report |
Jan 1, 2023 |
5310 |
| New Insights into the Use of Empagliflozin—A Comprehensive Review. |
Forycka, Joanna; Hajdys, Joanna; Krzeminska, Julia; Wilczopolski, Piotr; Wronka, Magdalena; Mlynarsk |
Report |
Dec 1, 2022 |
13082 |
| The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy. |
Kowalska, Klaudia; Wilczopolski, Piotr; Bulawska, Dominika; Mlynarska, Ewelina; Rysz, Jacek; Franczy |
Report |
Dec 1, 2022 |
10465 |
| Health Ministry, BPOM develop 16 domestic medicinal raw materials. |
|
|
Nov 9, 2022 |
358 |
| SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials. |
Ul Amin, Noor; Sabir, Faiza; Amin, Talal; Sarfraz, Zouina; Sarfraz, Azza; Robles-Velasco, Karla; Che |
Report |
Nov 1, 2022 |
7609 |
| The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction. |
Brust-Sisti, Lindsay; Rudawsky, Nicole; Gonzalez, Jimmy; Brunetti, Luigi |
Report |
Nov 1, 2022 |
8322 |
| Editorial for Special Issue: “Additive Manufacturing Approaches to Produce Drug Delivery Systems”. |
Valente, Joana F. A.; Alves, Nuno |
Editorial |
Nov 1, 2022 |
1823 |
| Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients. |
Silva-Nunes, José; Nascimento, Edite; Louro, Joana; Dores, Jorge; Laginha, Teresa; Gonçalves-Ferreir |
Report |
Nov 1, 2022 |
6250 |
| SGLT-2 Inhibitors in Cancer Treatment—Mechanisms of Action and Emerging New Perspectives. |
Dutka, Mieczyslaw; Bobinski, Rafal; Francuz, Tomasz; Garczorz, Wojciech; Zimmer, Karolina; Ilczak, T |
Report |
Nov 1, 2022 |
17400 |
| Empagliflozin and Dapagliflozin Increase Na[sup.+] and Inward Rectifier K[sup.+] Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells (hiPSC-CMs). |
Dago, María; Crespo-García, Teresa; Cámara-Checa, Anabel; Rapún, Josu; Rubio-Alarcón, Marcos; Marín, |
Report |
Nov 1, 2022 |
7762 |
| Beta-Hydroxybutyric Acid Inhibits Renal Tubular Reabsorption via the AKT/DAB2/Megalin Signalling Pathway. |
Zuo, Minxia; Meng, Cheng; Song, Qian; Gao, Zhongai; Cui, Xiao; Wang, Jingyu; Li, Yongmei |
|
Oct 25, 2022 |
6146 |
| Editorial—Current Insights on Lipid-Based Nanosystems. |
Silva, Ana Catarina; Moreira, João Nuno; Lobo, José Manuel Sousa |
Editorial |
Oct 1, 2022 |
2507 |
| Blocking Periostin Prevented Development of Inflammation in Rhabdomyolysis-Induced Acute Kidney Injury Mice Model. |
Muratsu, Jun; Sanada, Fumihiro; Koibuchi, Nobutaka; Shibata, Kana; Katsuragi, Naruto; Ikebe, Shoji; |
Report |
Oct 1, 2022 |
4475 |
| Greenness Assessment of Chromatographic Methods Used for Analysis of Empagliflozin: A Comparative Study. |
Santali, Eman Y.; Naguib, Ibrahim A.; Alshehri, Abdullah M.; Alzahrani, Yazeed A.; Alharthi, Abdulla |
|
Oct 1, 2022 |
5860 |
| Effect of Dapagliflozin on Exercise Capacity and Cardiovascular Risk in Patients with Heart Failure. |
Nazer, Rakan; Albratty, Mohammed; Aldhahi, Monira I.; Alqurashy, Maiasa; Halawi, Maryam A.; Albarrat |
Report |
Oct 1, 2022 |
5927 |
| Vericiguat in Heart Failure: Characteristics, Scientific Evidence and Potential Clinical Applications. |
Vannuccini, Francesca; Campora, Alessandro; Barilli, Maria; Palazzuoli, Alberto |
Report |
Oct 1, 2022 |
6710 |
| Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease. |
Hojná, Silvie; Kotsaridou, Zoe; Vanourková, Zdenka; Rauchová, Hana; Behuliak, Michal; Kujal, Petr; K |
Report |
Oct 1, 2022 |
5668 |
| The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study. |
Pignatelli, Pasquale; Baratta, Francesco; Buzzetti, Raffaella; D’Amico, Alessandra; Castellani, Vale |
Report |
Sep 1, 2022 |
5583 |
| Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives. |
Popa, Irene Paula; Haba, Mihai ?tefan Cristian; Maranduca, Minela Aida; Tanase, Daniela Maria; ?erba |
Report |
Sep 1, 2022 |
16561 |
| Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus. |
Berezin, Alexander A.; Lichtenauer, Michael; Boxhammer, Elke; Stöhr, Eric; Berezin, Alexander E. |
Report |
Sep 1, 2022 |
8199 |
| Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats. |
He, Xueru; Li, Ying; Ma, Yinling; Fu, Yuhao; Xun, Xuejiao; Cui, Yanjun; Dong, Zhanjun |
Report |
Sep 1, 2022 |
8345 |
| Acute Flaxseed Intake Reduces Postprandial Glycemia in Subjects with Type 2 Diabetes: A Randomized Crossover Clinical Trial. |
Moreira, Fernanda Duarte; Reis, Caio Eduardo Gonçalves; Welker, Alexis Fonseca; Gallassi, Andrea Don |
Report |
Sep 1, 2022 |
5523 |
| From Diabetes Care to Heart Failure Management: A Potential Therapeutic Approach Combining SGLT2 Inhibitors and Plant Extracts. |
Gliozzi, Micaela; Macrì, Roberta; Coppoletta, Anna Rita; Musolino, Vincenzo; Carresi, Cristina; Scic |
Report |
Sep 1, 2022 |
9200 |
| Changes in neutrophil-to-lymphocyte ratio following treatment with dapagliflozin in patients with type 2 diabetes mellitus. |
Bas, Suleyman; Turkmen, Funda Muserref |
|
Sep 1, 2022 |
3484 |
| Transition Metal Catalyzed Hiyama Cross-Coupling: Recent Methodology Developments and Synthetic Applications. |
Noor, Rida; Zahoor, Ameer Fawad; Irfan, Muhammad; Hussain, Syed Makhdoom; Ahmad, Sajjad; Irfan, Ali; |
Report |
Sep 1, 2022 |
21292 |
| AstraZeneca reports positive results from heart failure treatment trials. |
|
|
Aug 30, 2022 |
248 |
| AstraZeneca reports positive results from heart failure treatment trials. |
|
|
Aug 30, 2022 |
250 |
| AstraZeneca reports positive results from heart failure treatment trials. |
|
|
Aug 30, 2022 |
249 |
| Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China. |
Zhaohu, Hao; Xiao, Huang; Hailin, Shao; Feng, He |
|
Aug 13, 2022 |
6562 |
| Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein. |
Malínská, Hana; Hüttl, Martina; Marková, Irena; Miklánková, Denisa; Hojná, Silvie; Papoušek, Františ |
Report |
Aug 1, 2022 |
7729 |
| Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study. |
Patoulias, Dimitrios; Papadopoulos, Christodoulos; Zografou, Ioanna; Katsimardou, Alexandra; Karagia |
Report |
Aug 1, 2022 |
5176 |
| Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Urine Albumin to Creatinine Ratio in Type 2 Diabetes Mellitus Patients and Medication Care. |
Wang, Dong-Dong; Zhang, Cun; Yang, Yang; He, Su-Mei; Zhu, Ping; Chen, Xiao |
|
Jul 20, 2022 |
5179 |
| New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review. |
Gérard, Alexandre O.; Laurain, Audrey; Sicard, Antoine; Merino, Diane; Pathak, Atul; Drici, Milou-Da |
Report |
Jul 1, 2022 |
8005 |
| Association between Empagliflozin Use and Electrocardiographic Changes. |
Antwi-Amoabeng, Daniel; Sathappan, Sunil; Beutler, Bryce D.; Ulanja, Mark B.; Awad, Munadel; Gullapa |
|
Jul 1, 2022 |
4212 |
| Clinical and biochemical outcomes of Sodium-Glucose CoTransporter-2 (SGLT2) Inhibitors in Type-2 Diabetes Mellitus Patients as a fourth oral anti diabetic medicine. |
Muhammad Saleem, Sajjad Ali Khan, Zafar Aleem Suchal and Nanik Ram |
|
Jun 30, 2022 |
2322 |
| Health Care Quality in CKD Subjects: A Cross-Sectional In-Hospital Evaluation. |
Rzayeva, L.; Matyukhin, I.; Ritter, O.; Patschan, S.; Patschan, D. |
|
Jun 23, 2022 |
4527 |
| Clinic 'plugs gap' for heart patients with diabetes. |
SAM VOLPE Reporter [email protected] |
|
Jun 8, 2022 |
506 |
| Clinic leads way for patient care. |
SAM VOLPE Health reporter [email protected] |
|
Jun 8, 2022 |
431 |
| How a UK-first clinic in Gateshead sees pharmacists transform care for heart failure and diabetes patients; Pharmacists in Gateshead have created an innovative new clinic to better treat patients who have both heart failure and diabetes. |
By, Sam Volpe |
|
Jun 7, 2022 |
546 |
| AstraZeneca's Farxiga Met Primary Endpoint in DELIVER Phase III trial, Reducing Risk of Cardiovascular Death. |
|
|
May 9, 2022 |
725 |
| Cardiac effects of dapagliflozin in diabetic rats with subacute exposure. |
Boran, Tugce; Karaca, Bahar Ulus; Koroglu, Ayca Karagoz; Kaptan, Engin; Ercan, Feriha; Ozhan, Gul |
|
Apr 1, 2022 |
3755 |
| Cardiac effects of dapagliflozin in diabetic rats with subacute exposure. |
Boran, Tugce; Karaca, Bahar Ulus; Koroglu, Ayca Karagoz; Kaptan, Engin; Ercan, Feriha; Ozhan, Gul |
|
Apr 1, 2022 |
3620 |
| Is Dapagliflozin future for CKD? |
Yumna Zafar, Yusra Iqbal and Syeda Sanila Aijaz |
|
Mar 31, 2022 |
458 |
| FDA okays pill for chronic kidney disease. |
|
|
Mar 11, 2022 |
419 |
| Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy. |
Benko, Jakub; Samoš, Matej; Bolek, Tomáš; Prídavková, Dana; Jurica, Jakub; Péc, Martin Jozef; Galajd |
|
Mar 7, 2022 |
9720 |
| Comparison of Effect of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors with Dipeptidyl Peptidase-4 (DPP-4) Inhibitors on HBA1c Level in Type 2 Diabetes in Pakistani Population. |
Muhammad Amir Misbah Ul Qamar, Tahira Sumreen, Andaleeb Khan, Kamil Rehman Butt, Ejaz Ali and Ayesha |
|
Feb 28, 2022 |
2287 |
| SHORT COMMUNICATION - Ventricular-arterial coupling as a potential therapeutic target in diabetes. |
Saeed, Sahrai; Holm, Hannes; Nilsson, Peter |
Report |
Nov 30, 2021 |
2259 |
| Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan. |
Bhagwan Das, Aisha Sheikh, Bilal Ahmed and Najmul Islam |
|
Oct 22, 2021 |
2839 |
| Dapagliflozin: The outcome of use as add-on therapy in real-life clinical setting-An Audit. |
Raja, Umar Yousaf; Saravanan, Ponnusamy |
Report |
Sep 15, 2021 |
1418 |
| Safety of the new anti-diabetic medications. |
|
|
Jul 3, 2021 |
518 |
| Use of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease. |
Mottl, Amy |
Report |
Jul 1, 2021 |
4347 |
| American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. |
|
|
Jun 28, 2021 |
254 |
| American Diabetes Association's clinical trial finds dapagliflozin was well tolerated in hospitalised COVID-19 patients. |
|
|
Jun 28, 2021 |
253 |
| DARE-19 Trial Finds Dapagliflozin Well Tolerated in Hospitalized COVID-19 Patients. |
|
|
Jun 28, 2021 |
531 |
| AstraZeneca's Farxiga gets US approval in chronic kidney disease. |
|
|
May 5, 2021 |
213 |
| AstraZeneca's Farxiga gets US approval in chronic kidney disease. |
|
|
May 5, 2021 |
211 |
| AstraZeneca's Farxiga gets US approval in chronic kidney disease. |
|
|
May 5, 2021 |
212 |
| AstraZeneca hails progress on chronic kidney disease with US approval. |
|
|
May 3, 2021 |
218 |
| TOP NEWS SUMMARY: Eurozone manufacturing growth "stellar" in April. |
|
|
May 3, 2021 |
1567 |
| Farxiga Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression with and without Type 2 Diabetes. |
|
|
May 3, 2021 |
232 |
| Sugar or Fat? Renal Tubular Metabolism Reviewed in Health and Disease. |
Gewin, Leslie S. |
|
May 1, 2021 |
9149 |
| A Brief Review of the Mechanisms of ß-Cell Dedifferentiation in Type 2 Diabetes. |
Khin, Phyu-Phyu; Lee, Jong-Han; Jun, Hee-Sook |
|
May 1, 2021 |
7459 |
| SGLT2 inhibitors: A revolution in therapeutics of a Major Non-Communicable Disease. |
Khan, Muhammad Sami |
|
Apr 30, 2021 |
676 |
| Phase 3 trial of diabetes drug Farxiga showed it did not help hospitalised COVID-19 patients. |
|
|
Apr 12, 2021 |
256 |
| Phase 3 trial of diabetes drug Farxiga showed it did not help hospitalised COVID-19 patients. |
|
|
Apr 12, 2021 |
255 |
| Medicines to help asthma and migraines among drugs given green light for use in Scotland; Four new medicines to help severe asthma, migraines, heart failure and bone marrow cancer have been approved for use by NHS Scotland. |
Gary Flockhart |
|
Apr 12, 2021 |
422 |
| Heart Failure Is a Treatable Condition, Not a Death Sentence: Manage heart failure with medication, a low-sodium diet, and other lifestyle choices to enjoy a full, active life. |
|
|
Mar 31, 2021 |
1047 |
| SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute(MIDEM). |
Erum Sohail, Tasnim Ahsan, Saima Ghaus and Wasfa Aijaz |
|
Feb 24, 2021 |
3564 |
| New drug for heart failure gets FDA approval. |
|
|
Feb 18, 2021 |
774 |
| FDA approves AstraZeneca's Dapagliflozin to treat heart failure. |
|
|
Feb 1, 2021 |
591 |
| AstraZeneca's Farxiga granted FDA Priority Review for treatment of chronic kidney disease. |
|
|
Jan 6, 2021 |
303 |
| AstraZeneca's Farxiga granted FDA Priority Review for treatment of chronic kidney disease. |
|
|
Jan 6, 2021 |
299 |
